These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Immunohistochemical characteristics of atypical polypoid adenomyoma with special reference to h-caldesmon. Horita A; Kurata A; Maeda D; Fukayama M; Sakamoto A Int J Gynecol Pathol; 2011 Jan; 30(1):64-70. PubMed ID: 21131830 [TBL] [Abstract][Full Text] [Related]
3. Patterns of SATB2 and p16 reactivity aid in the distinction of atypical polypoid adenomyoma from myoinvasive endometrioid carcinoma and benign adenomyomatous polyp on endometrial sampling. Worrell HI; Sciallis AP; Skala SL Histopathology; 2021 Jul; 79(1):96-105. PubMed ID: 33459390 [TBL] [Abstract][Full Text] [Related]
4. Stromal p16 Expression Helps Distinguish Atypical Polypoid Adenomyoma From Myoinvasive Endometrioid Carcinoma of the Uterus. Kihara A; Amano Y; Yoshimoto T; Matsubara D; Fukushima N; Fujiwara H; Niki T Am J Surg Pathol; 2019 Nov; 43(11):1526-1535. PubMed ID: 31600177 [TBL] [Abstract][Full Text] [Related]
5. CD10 imunostaining does not distinguish endometrial carcinoma invading myometrium from carcinoma involving adenomyosis. Srodon M; Klein WM; Kurman RJ Am J Surg Pathol; 2003 Jun; 27(6):786-9. PubMed ID: 12766582 [TBL] [Abstract][Full Text] [Related]
6. The role of CD10 staining in distinguishing invasive endometrial adenocarcinoma from adenocarcinoma involving adenomyosis. Nascimento AF; Hirsch MS; Cviko A; Quade BJ; Nucci MR Mod Pathol; 2003 Jan; 16(1):22-7. PubMed ID: 12527709 [TBL] [Abstract][Full Text] [Related]
7. Immunophenotype of Atypical Polypoid Adenomyoma of the Uterus: Diagnostic Value and Insight on Pathogenesis. Travaglino A; Raffone A; Saccone G; Fuggi M; De Placido G; Mascolo M; Mollo A; Insabato L; Zullo F Appl Immunohistochem Mol Morphol; 2020 Sep; 28(8):646-653. PubMed ID: 31855579 [TBL] [Abstract][Full Text] [Related]
8. Atypical polypoid adenomyofibroma (APA) versus well-differentiated endometrial carcinoma with prominent stromal matrix: an immunohistochemical study. Soslow RA; Chung MH; Rouse RV; Hendrickson MR; Longacre TA Int J Gynecol Pathol; 1996 Jul; 15(3):209-16. PubMed ID: 8811381 [TBL] [Abstract][Full Text] [Related]
9. Adenomyosis involved by endometrial adenocarcinoma is a significant risk factor for deep myometrial invasion. Ismiil N; Rasty G; Ghorab Z; Nofech-Mozes S; Bernardini M; Ackerman I; Thomas G; Covens A; Khalifa MA Ann Diagn Pathol; 2007 Aug; 11(4):252-7. PubMed ID: 17630108 [TBL] [Abstract][Full Text] [Related]
10. Uterine adenomyoma: a clinicopathologic review of 26 cases and a review of the literature. Tahlan A; Nanda A; Mohan H Int J Gynecol Pathol; 2006 Oct; 25(4):361-5. PubMed ID: 16990713 [TBL] [Abstract][Full Text] [Related]
11. Significance of stromal markers in atypical polypoid adenomyoma. Travaglino A; Raffone A; Gencarelli A; Zullo F; Di Spiezio Sardo A; Insabato L Pathol Res Pract; 2020 Nov; 216(11):153133. PubMed ID: 32823231 [TBL] [Abstract][Full Text] [Related]
12. Unusual epithelial and stromal changes in myoinvasive endometrioid adenocarcinoma: a study of their frequency, associated diagnostic problems, and prognostic significance. Murray SK; Young RH; Scully RE Int J Gynecol Pathol; 2003 Oct; 22(4):324-33. PubMed ID: 14501811 [TBL] [Abstract][Full Text] [Related]
13. Coexistent atypical polypoid adenomyoma and complex atypical endometrial hyperplasia in the uterus. Horita A; Kurata A; Komatsu K; Yajima M; Sakamoto A Diagn Cytopathol; 2010 Jul; 38(7):527-32. PubMed ID: 19950396 [TBL] [Abstract][Full Text] [Related]
14. Case of atypical polypoid adenomyoma that possibly underwent a serial progression from endometrial hyperplasia to carcinoma. Fukuda M; Sakurai N; Yamamoto Y; Taoka H; Asakawa Y; Kurasaki A; Oharaseki T; Takahashi K; Kubushiro K J Obstet Gynaecol Res; 2011 May; 37(5):468-71. PubMed ID: 21272150 [TBL] [Abstract][Full Text] [Related]
15. Adenomyosis is associated with myometrial invasion by FIGO 1 endometrial adenocarcinoma. Ismiil ND; Rasty G; Ghorab Z; Nofech-Mozes S; Bernardini M; Thomas G; Ackerman I; Covens A; Khalifa MA Int J Gynecol Pathol; 2007 Jul; 26(3):278-83. PubMed ID: 17581412 [TBL] [Abstract][Full Text] [Related]
16. Paraffin-section detection of CD10 in 505 nonhematopoietic neoplasms. Frequent expression in renal cell carcinoma and endometrial stromal sarcoma. Chu P; Arber DA Am J Clin Pathol; 2000 Mar; 113(3):374-82. PubMed ID: 10705818 [TBL] [Abstract][Full Text] [Related]
17. [Myxoid mesenchymal tumors of uterus: endometrial stromal and smooth muscle tumors, myxoid variant]. Chesnais AL; Watkin E; Beurton D; Devouassoux-Shisheboran M Ann Pathol; 2011 Jun; 31(3):152-8. PubMed ID: 21736994 [TBL] [Abstract][Full Text] [Related]
18. Atypical polypoid adenomyofibromas (atypical polypoid adenomyomas) of the uterus. A clinicopathologic study of 55 cases. Longacre TA; Chung MH; Rouse RV; Hendrickson MR Am J Surg Pathol; 1996 Jan; 20(1):1-20. PubMed ID: 8540600 [TBL] [Abstract][Full Text] [Related]
19. Frequent β-catenin gene mutations in atypical polypoid adenomyoma of the uterus. Takahashi H; Yoshida T; Matsumoto T; Kameda Y; Takano Y; Tazo Y; Inoue H; Saegusa M Hum Pathol; 2014 Jan; 45(1):33-40. PubMed ID: 24182564 [TBL] [Abstract][Full Text] [Related]
20. Intraepithelial mucinous carcinoma arising in an endocervical-type mucinous polypoid adenomyoma of the uterine corpus: a case report. Quddus MR; Zhang C; Sung CJ; Ramos D; Lawrence WD J Reprod Med; 2005 Aug; 50(8):643-6. PubMed ID: 16220776 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]